Mirvetuximab
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1) . Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antifolate
CAS Number
1453084-36-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IRBAMLNOS1AP65200UL 200 µL
Rabbit Anti Human NOS1 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4) (Western Blot,IHC) 200UL
Ask
View Details 
IRTAMSCD90230H12CFITC100 100 Tests
Anti Mouse CD90.2 Flow Cytometry Monoclonal Clone 30H12 FITC Ready To Use 100 Tests
Ask
View Details